AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

PrEP

HIV Vaccine and Cure Research Highlights from IAS 2015

"8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).
Vancouver, Canada.
Copyright: Marcus Rose/IAS
Image Shows: (WEPL01) Co-chair: Quarraisha Abdool Karim, Centre for the AIDS Programme of Research in South Africa, South Africa"

As the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) came to a close in Vancouver, Canada, we spoke one last time by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to learn about some of the…

PrEP and Additional Benefits of HIV Treatment Among Science Highlights from IAS 2015

"8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).
Vancouver, Canada.
Copyright: Marcus Rose/IAS
Image Shows: (WEPL01) Co-chair: Quarraisha Abdool Karim, Centre for the AIDS Programme of Research in South Africa, South Africa"

More HIV research findings were shared yesterday as the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) continued in Vancouver, Canada. We spoke by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to learn about some of…

CDC and NIH Share PrEP Research at IAS 2015

IAS2015 logo crop2

New findings on pre-exposure prophylaxis (PrEP) from both CDC and NIH were among the HIV research findings shared on July 21 at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) in Vancouver, Canada.  Below are highlights of some of the information they have shared. CDC Study Finds High Adherence…

NIH’s Dr. Carl Dieffenbach Shares Highlights as IAS 2015 Begins

IAS2015 logo crop2

After the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) got underway in Vancouver, Canada yesterday, July 20, we spoke by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He shared some highlights from the first full…

An Era of New Possibilities: HIV Prevention for Gay and Bisexual Men

CDC Logo

We have achieved some hard-won victories against HIV in recent years. New infections among women and injection drug users are declining, people with HIV are living longer, and more people than ever know their HIV status.  But one population — gay and bisexual men –is seeing infections rise, driven by increases among young gay men….

Final CROI 2015 Highlights from NIH’s Dr. Carl Dieffenbach

Carl Dieffenbach - NIH - CROI2015

As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle came to a close on Thursday, February 26, we spoke again with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID) about a highlight from the day’s presentations as well as his reflections as the…

Conversations from CROI 2015: White House Director of ONAP – Douglas Brooks

IMG_6985

While at the 2015 Conference on Retroviruses and Opportunistic Infections  (CROI) this week in Seattle, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, had the opportunity to talk with Mr. Douglas Brooks, Director of the White House Office of National AIDS Policy (ONAP). Amidst presentations on the latest advances in HIV science from…

NIH’s Dr. Carl Dieffenbach Shares Highlights from First Day of CROI 2015 (Video)

Carl Dieffenbach - NIH - CROI2015

After the first full day of sessions at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle yesterday, February 24, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to get his take on some of the key highlights of…